{"id":52518,"date":"2023-01-04T14:02:30","date_gmt":"2023-01-04T13:02:30","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/imperative-care-announces-fda-clearance-and-initial-cases-of-zoom-rdl-the-first-stroke-specific-radial-access-platform-for-mechanical-thrombectomy\/"},"modified":"2023-01-04T14:02:30","modified_gmt":"2023-01-04T13:02:30","slug":"imperative-care-announces-fda-clearance-and-initial-cases-of-zoom-rdl-the-first-stroke-specific-radial-access-platform-for-mechanical-thrombectomy","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/imperative-care-announces-fda-clearance-and-initial-cases-of-zoom-rdl-the-first-stroke-specific-radial-access-platform-for-mechanical-thrombectomy\/","title":{"rendered":"Imperative Care Announces FDA Clearance and Initial Cases of Zoom RDL, the First Stroke-Specific Radial Access Platform for Mechanical Thrombectomy"},"content":{"rendered":"
\n

\n– First Patient Treated with Zoom RDL at Spectrum Health <\/i>–<\/i><\/b>\n<\/p>\n

\n– Newest Addition to Company\u2019s Zoom Stroke Solution Provides an Additional Option for Achieving Intracranial Access to Treat Patients for Ischemic Stroke <\/i>–<\/i><\/b>\n<\/p>\n

CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, Inc.<\/a>, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its Zoom\u2122 RDL Radial Access System, the company\u2019s latest innovation in elevating stroke care and the first radial access platform developed specifically for ischemic stroke treatment.\n<\/p>\n

<\/a><\/p>\n

\nZoom RDL is the newest addition to Imperative Care\u2019s Zoom Stroke Solution\u2122, the company\u2019s ischemic stroke product portfolio that includes the Zoom 88 Large Distal Platform (LDP) for neurovascular access, four purposefully designed vessel-matching Zoom Aspiration Catheters, and the powerful Zoom Pump with Zoom POD for sterile-field clot capture.\n<\/p>\n

\nThe company also announced the successful completion of the first in-human case using Zoom RDL, which was performed by Dr. Justin Singer, M.D., Neurosurgeon at Spectrum Health in Grand Rapids, Michigan. The Zoom RDL was used during treatment of an acute stroke for a patient with a complex anatomy that would have made femoral access challenging. The Zoom RDL provided .088\u201d intracranial access from the radial artery allowing the physician to remove the clot using a Zoom Aspiration Catheter and achieve complete revascularization in less than 20 minutes.\n<\/p>\n

\n\u201cWe are excited to offer a new capability in our patient-first portfolio, empowering physicians with both femoral and radial access options to care for their patients for the best possible outcomes,\u201d said Daniel Davis, President and COO of Imperative Care. \u201cWe are committed to providing meaningful solutions that directly address the feedback and needs of physicians through continued innovation of the Zoom Stroke Solution. A radial approach can be beneficial for patients with unfavorable femoral access and can make access site recovery easier for the patient.\u201d\n<\/p>\n

\n\u201cWe are in a new era of stroke thrombectomy, and Zoom RDL is an important part of this evolution that will allow physicians to get closer to the treatment site for quicker, more efficient stroke procedures without compromising device selection,\u201d said Davis.\n<\/p>\n

\nThe introduction of Zoom RDL provides neurointerventionalists with a new option for achieving intracranial access to treat their stroke patients, enabling the best possible outcome based on an individual patient\u2019s anatomy. Zoom RDL features an extended hydrophilic coating and the longest optimized vessel dilator on the market, providing a smooth introduction into the radial artery. Similar to the company\u2019s FDA-cleared Zoom 88 Large Distal Platform for femoral access, Zoom RDL features a large .088\u201d lumen for compatibility with large-bore aspiration catheters. With an engineered support profile designed to reach the intracranial vasculature, physicians can get higher into the brain and closer to the stroke-causing clot, giving them more control over the mechanical thrombectomy procedure.\n<\/p>\n

\n\u201cAs we continue to advance how we care for our stroke patients and see the overwhelming benefit of performing radial interventions, it\u2019s remarkable to have a company like Imperative Care respond with much-needed tools for a radial approach,\u201d said Dr. Singer. \u201cI am impressed with the performance of the Zoom RDL in my initial experience and look forward to continuing a patient-first approach in my stroke practice. The addition of this new technology will allow me the first capability to choose the best access approach for each patient without limitations.\u201d\n<\/p>\n

\nAbout the Zoom Stroke Solution<\/b>\n<\/p>\n

\nThe Zoom Stroke Solution is the complete stroke system from access through reperfusion for fast and effective clot removal for patients with acute ischemic stroke. The system includes the Zoom 88 Large Distal Platform for neurovascular access, four vessel-matched Zoom Aspiration Catheters, the Zoom Pump, the Zoom POD and accessories. All Zoom catheters are designed with the TRX\u2122 Tip which provides 15% greater clot engagement area at the tip of the catheter and are designed to enable smooth tracking through challenging vasculature. For complete product information, including indications, contraindications, warnings, precautions and adverse events visit: http:\/\/bit.ly\/2Vx0Qcf<\/a>\n<\/p>\n

\nAbout Imperative Care, Inc.<\/b>\n<\/p>\n

\nImperative Care is a commercial-stage medical technology company developing connected innovations to elevate care for people affected by devastating vascular diseases such as stroke and pulmonary embolism. The company is addressing specific gaps in treatment and care to make an impact across the entire patient journey. Imperative Care is based in Campbell, Calif. https:\/\/imperativecare.com<\/a>.\n<\/p>\n

\nDr. Justin Singer is a paid consultant of Imperative Care.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nInvestor Contact:<\/b>
Matt Garrett, CFO
\n
Imperative Care, Inc.
\n
408-476-1672
\n
mgarrett@imperativecare.com<\/a>\n<\/p>\n

\nMedia Contact:<\/b>
Lara Lingenbrink
\n
Imperative Care, Inc.
\n
858-525-1414
\n
llingenbrink@imperativecare.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

– First Patient Treated with Zoom RDL at Spectrum Health – – Newest Addition to Company\u2019s Zoom Stroke Solution Provides an Additional Option for Achieving Intracranial Access to Treat Patients for Ischemic Stroke – CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, Inc., today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its Zoom\u2122 RDL Radial Access … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-52518","6":"format-standard","7":"category-industry"},"yoast_head":"\nImperative Care Announces FDA Clearance and Initial Cases of Zoom RDL, the First Stroke-Specific Radial Access Platform for Mechanical Thrombectomy - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/imperative-care-announces-fda-clearance-and-initial-cases-of-zoom-rdl-the-first-stroke-specific-radial-access-platform-for-mechanical-thrombectomy\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Imperative Care Announces FDA Clearance and Initial Cases of Zoom RDL, the First Stroke-Specific Radial Access Platform for Mechanical Thrombectomy - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"– First Patient Treated with Zoom RDL at Spectrum Health – – Newest Addition to Company\u2019s Zoom Stroke Solution Provides an Additional Option for Achieving Intracranial Access to Treat Patients for Ischemic Stroke – CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, Inc., today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its Zoom\u2122 RDL Radial Access ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/imperative-care-announces-fda-clearance-and-initial-cases-of-zoom-rdl-the-first-stroke-specific-radial-access-platform-for-mechanical-thrombectomy\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-04T13:02:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230104005059\/en\/1674654\/21\/Imperative_Care_Primary_Logo_RGB_M02_-_BW.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/imperative-care-announces-fda-clearance-and-initial-cases-of-zoom-rdl-the-first-stroke-specific-radial-access-platform-for-mechanical-thrombectomy\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/imperative-care-announces-fda-clearance-and-initial-cases-of-zoom-rdl-the-first-stroke-specific-radial-access-platform-for-mechanical-thrombectomy\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Imperative Care Announces FDA Clearance and Initial Cases of Zoom RDL, the First Stroke-Specific Radial Access Platform for Mechanical Thrombectomy\",\"datePublished\":\"2023-01-04T13:02:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/imperative-care-announces-fda-clearance-and-initial-cases-of-zoom-rdl-the-first-stroke-specific-radial-access-platform-for-mechanical-thrombectomy\\\/\"},\"wordCount\":771,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/imperative-care-announces-fda-clearance-and-initial-cases-of-zoom-rdl-the-first-stroke-specific-radial-access-platform-for-mechanical-thrombectomy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230104005059\\\/en\\\/1674654\\\/21\\\/Imperative_Care_Primary_Logo_RGB_M02_-_BW.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/imperative-care-announces-fda-clearance-and-initial-cases-of-zoom-rdl-the-first-stroke-specific-radial-access-platform-for-mechanical-thrombectomy\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/imperative-care-announces-fda-clearance-and-initial-cases-of-zoom-rdl-the-first-stroke-specific-radial-access-platform-for-mechanical-thrombectomy\\\/\",\"name\":\"Imperative Care Announces FDA Clearance and Initial Cases of Zoom RDL, the First Stroke-Specific Radial Access Platform for Mechanical Thrombectomy - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/imperative-care-announces-fda-clearance-and-initial-cases-of-zoom-rdl-the-first-stroke-specific-radial-access-platform-for-mechanical-thrombectomy\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/imperative-care-announces-fda-clearance-and-initial-cases-of-zoom-rdl-the-first-stroke-specific-radial-access-platform-for-mechanical-thrombectomy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230104005059\\\/en\\\/1674654\\\/21\\\/Imperative_Care_Primary_Logo_RGB_M02_-_BW.jpg\",\"datePublished\":\"2023-01-04T13:02:30+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/imperative-care-announces-fda-clearance-and-initial-cases-of-zoom-rdl-the-first-stroke-specific-radial-access-platform-for-mechanical-thrombectomy\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/imperative-care-announces-fda-clearance-and-initial-cases-of-zoom-rdl-the-first-stroke-specific-radial-access-platform-for-mechanical-thrombectomy\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/imperative-care-announces-fda-clearance-and-initial-cases-of-zoom-rdl-the-first-stroke-specific-radial-access-platform-for-mechanical-thrombectomy\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230104005059\\\/en\\\/1674654\\\/21\\\/Imperative_Care_Primary_Logo_RGB_M02_-_BW.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230104005059\\\/en\\\/1674654\\\/21\\\/Imperative_Care_Primary_Logo_RGB_M02_-_BW.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/imperative-care-announces-fda-clearance-and-initial-cases-of-zoom-rdl-the-first-stroke-specific-radial-access-platform-for-mechanical-thrombectomy\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Imperative Care Announces FDA Clearance and Initial Cases of Zoom RDL, the First Stroke-Specific Radial Access Platform for Mechanical Thrombectomy\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Imperative Care Announces FDA Clearance and Initial Cases of Zoom RDL, the First Stroke-Specific Radial Access Platform for Mechanical Thrombectomy - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/imperative-care-announces-fda-clearance-and-initial-cases-of-zoom-rdl-the-first-stroke-specific-radial-access-platform-for-mechanical-thrombectomy\/","og_locale":"en_US","og_type":"article","og_title":"Imperative Care Announces FDA Clearance and Initial Cases of Zoom RDL, the First Stroke-Specific Radial Access Platform for Mechanical Thrombectomy - Pharma Trend","og_description":"– First Patient Treated with Zoom RDL at Spectrum Health – – Newest Addition to Company\u2019s Zoom Stroke Solution Provides an Additional Option for Achieving Intracranial Access to Treat Patients for Ischemic Stroke – CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, Inc., today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its Zoom\u2122 RDL Radial Access ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/imperative-care-announces-fda-clearance-and-initial-cases-of-zoom-rdl-the-first-stroke-specific-radial-access-platform-for-mechanical-thrombectomy\/","og_site_name":"Pharma Trend","article_published_time":"2023-01-04T13:02:30+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230104005059\/en\/1674654\/21\/Imperative_Care_Primary_Logo_RGB_M02_-_BW.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/imperative-care-announces-fda-clearance-and-initial-cases-of-zoom-rdl-the-first-stroke-specific-radial-access-platform-for-mechanical-thrombectomy\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/imperative-care-announces-fda-clearance-and-initial-cases-of-zoom-rdl-the-first-stroke-specific-radial-access-platform-for-mechanical-thrombectomy\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Imperative Care Announces FDA Clearance and Initial Cases of Zoom RDL, the First Stroke-Specific Radial Access Platform for Mechanical Thrombectomy","datePublished":"2023-01-04T13:02:30+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/imperative-care-announces-fda-clearance-and-initial-cases-of-zoom-rdl-the-first-stroke-specific-radial-access-platform-for-mechanical-thrombectomy\/"},"wordCount":771,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/imperative-care-announces-fda-clearance-and-initial-cases-of-zoom-rdl-the-first-stroke-specific-radial-access-platform-for-mechanical-thrombectomy\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230104005059\/en\/1674654\/21\/Imperative_Care_Primary_Logo_RGB_M02_-_BW.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/imperative-care-announces-fda-clearance-and-initial-cases-of-zoom-rdl-the-first-stroke-specific-radial-access-platform-for-mechanical-thrombectomy\/","url":"https:\/\/pharma-trend.com\/en\/imperative-care-announces-fda-clearance-and-initial-cases-of-zoom-rdl-the-first-stroke-specific-radial-access-platform-for-mechanical-thrombectomy\/","name":"Imperative Care Announces FDA Clearance and Initial Cases of Zoom RDL, the First Stroke-Specific Radial Access Platform for Mechanical Thrombectomy - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/imperative-care-announces-fda-clearance-and-initial-cases-of-zoom-rdl-the-first-stroke-specific-radial-access-platform-for-mechanical-thrombectomy\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/imperative-care-announces-fda-clearance-and-initial-cases-of-zoom-rdl-the-first-stroke-specific-radial-access-platform-for-mechanical-thrombectomy\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230104005059\/en\/1674654\/21\/Imperative_Care_Primary_Logo_RGB_M02_-_BW.jpg","datePublished":"2023-01-04T13:02:30+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/imperative-care-announces-fda-clearance-and-initial-cases-of-zoom-rdl-the-first-stroke-specific-radial-access-platform-for-mechanical-thrombectomy\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/imperative-care-announces-fda-clearance-and-initial-cases-of-zoom-rdl-the-first-stroke-specific-radial-access-platform-for-mechanical-thrombectomy\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/imperative-care-announces-fda-clearance-and-initial-cases-of-zoom-rdl-the-first-stroke-specific-radial-access-platform-for-mechanical-thrombectomy\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230104005059\/en\/1674654\/21\/Imperative_Care_Primary_Logo_RGB_M02_-_BW.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230104005059\/en\/1674654\/21\/Imperative_Care_Primary_Logo_RGB_M02_-_BW.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/imperative-care-announces-fda-clearance-and-initial-cases-of-zoom-rdl-the-first-stroke-specific-radial-access-platform-for-mechanical-thrombectomy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Imperative Care Announces FDA Clearance and Initial Cases of Zoom RDL, the First Stroke-Specific Radial Access Platform for Mechanical Thrombectomy"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/52518","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=52518"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/52518\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=52518"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=52518"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=52518"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}